Concourse Financial Group Securities, Inc. Dyne Therapeutics, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
213Shares Held
125MCall Options Held
36.5KPut Options Held
74.3K-
Vanguard Group Inc Valley Forge, PA9.76MShares$182 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$181 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$176 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$171 Million19.12% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$138 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $967M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...